alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
EPA TESTIMONY, MAY 24, 20I2 

My name is Liane Casten: !live at I030 Asbury Ave. Evanston. IL 

I am here to testify about the issues surrounding the coal fired plants and their carbon 

emiSSIOnS. 

There is not one of you here who is not aware of the consequences to human health and 

the environment because of the excess of carbon in the atmosphere. You would not be 

sitting where you arc listening to citizens like me if you were not qualified to fully 

understand the issues. 

So I am not going to discuss the health effects or the environmental effects. I am going 

to discuss the politics and the kmd of climate where this hearing is even necessary. 

Years ago, after deep citizen anger, EPA was commissioned to do a thorough analysis of 

the deadly chemical dioxin---the contaminant in Agent Orange. Thev did the study and it 

was damning--full of scientific information capable of causing serious legal headaches 

for those chemical companies like Dow and Monsanto that made Agent Orange during 

the Vietnam war. I ha\·e the studies. Under corporate and government pressure, EPA 

never published the findings. This. despite a second round of exacting studies. EPA 

buckled. The companies were protected. 

Now. some 40 years later, things are worse. I have not seen so much cruel contention 

and ugliness around environmental issues as I do now. I see the development of a value 

system where today, more than ever, profits are being put ahead of human health, the 

health of our future children and the health of this very precious planet. And that includes 

mv own very special t,>Tandchildren. I see a callous indifference to life, false science 

created to promote what is indefensible and a total disregard of that which created the 

EPA in the first place. I see corruption. So instead of simply doing what is right, just 

and logical, EPA must hold these hearings to bolster what is completely within your 

power to act. 

So, 1 just urge you all to do what is right. Protect the health of our citizens and the health 

of our planet. You are all probably under some tough pressure Hold fast and help 

create a world where we may all be ahle to breathe clean air and drink our water 

unpolluted hy emissions-- with safety and a sense of security. It's really that simple. 

Thank you.
Debt Management Modeling

U.S. Department 

Office of Deb
Office of Debt Management

Debt Management Model: Update

 Key Inputs: 

– Macro Variables: GDP, CPI, Deficits– Yields: Nominal and Real Yield Curves, Volatilities– Auction Calendar

 Key Policy Instrument

– Issuance Strategy

 Key Outputs: Steady State Portfolio Characteristics

– Mean and Variance of Interest Costs– Debt Turnover– Other portfolio characteristics

 Have developed a “beta test version” of the model
Office of Debt Management

Outputs: Scenario Analysis

 Develop a baseline scenario Use baseline as a benchmark in consideration of alternati

 Key parameters set to roughly match current portfolio

– Debt/GDP ratio – Portfolio Composition

• Maturity• Nominal versus inflation-indexed
Office of Debt Management

A Few Sample Outputs from the Baseline

 Debt to GDP Ratio Mean Interest Cost Interest Cost “Smoothness” Interest Cost Uncertainty Deficit Uncertainty Cash Balance Uncertainty
Office of Debt Management

Evaluation of Alternatives

 Consider implications of alternative maturity composition o

 Hypothetical Alternative 1: Short End Tilt Hypothetical Alternative 2: Long End Tilt
Office of Debt Management

Examples of Possible Evaluation Criteria

Debt to GDP Ratio

0.380.39

0.4

0.41

Long End TiltBaselineShort End Tilt

Average Interest Cost

0.039

0.04

0.041

Long End TiltBaselineShort End Tilt

Interest Cost Smoothness

0

0.040.08

Long End TiltBaselineShort End Tilt

Interest Cost Uncertainty

0

0.0040.0080.012

Long End TiltBaselineShort End Tilt

Deficit Unce

0.00870.00880.0089

0.009

0.0091

Long End TiltBaselineShort End Tilt

Residual Un

0

0.0010.0020.003
Office of Debt Management

Other Types of Analysis

 New securities Changes in auction schedule Changes in economic parameters Tail Risks
Office of Debt Management

Comments/Next Steps

 Continue to develop model

– Still very preliminary– Consult with Board and FRBNY– Consult with Other Debt Issuers

 Develop standard charts for Committee’s consideration
Proposal for 30-year Bond 

U.S. Department 

Office of Deb
Office of Debt Management

Interest Rate Risk (DV01 Risk) Adjusted for I

05

101520253035404550

Feb-85

Aug-85

Feb-86

Aug-86

Feb-87

Aug-87

Feb-88

Aug-88

Feb-89

Aug-89

Feb-90

Aug-90

Feb-91

Aug-91

Feb-92

Aug-92

Feb-93

Aug-93

Feb-94

Aug-94

Feb-95

Aug-95

Feb-96

Aug-96

Feb-97

Aug-97

Feb-98

Aug-98

Feb-99

Aug-99

Feb-00

Aug-00

Feb-01

Aug-01

Feb-02

Aug-02

Feb-03

Aug03

Refunding Date

$ Million 

Average Refunding DV01: $27.0 million

Max: $47.5m Nov 86

 May 00Min: $12.6
Office of Debt Management

Average Maturity of Issuance and Average Maturity o

Outstanding Debt Assuming Quarterly 30-year Bond 

2030405060708090

1981 1983 1985 1987 1989 1991 1993 1995 1997 1999 2001 2003 2005 2007 

months

Average Maturity of Issuance 

Average Maturity of Marketable Debt Outstanding

Proje

With Quarterly Issua
Case 3:22-cr-00145-M Document 317 Filed 09/05/23 Page 1 of 1 PageID 832
TINITED STATES OF AMERICA

BRrAN rRVrN (l)

IN TI{E UNITED STATES DISTRICT COURT

FOR T}IE NORTHERN DISTRICT OF TEXAS

DALLAS DIVISION

CASENO.:3:22-CR a-ltr

NORT ERN

By

OF TEXAS

AUG 1 6 2022

$

$

$

$

$

REPORT AND RECOMMEI\IDATION

CONCER}TING PLEA OF GTIILTY

BRIA|I IRVIN (1), by consent, under authority of United States v. Dees, 125 F.3d26l (5th Cir. 1997), has

appeared before me pursuant to Fed. R. Crim.P. I l, and has entered a plea of guilty to Count(s) I of the Indictment After

cautioning and examining BRIAN IRVIN (l) under oath concerning each of the subjects mentioned in Rule 11, I

determined that the guilty plea was knowledgeable and voluntary and that the offense(s) charged is supported by an

independent basis in fact containing each of the essential elements of such offense. I therefore recommend that the plea of

guilty be accepted, and that BRIAN IRVIN (l) be adjudged guilty of l8 U.S.C. $$ 922(gxl) and 92a@)Q) Possession of

a Firgarm by a Convicted Felon and have sentence imposed accordingly. After being found guilty of the offense by the

dist/ct judge,

/

V The defendant is currently in custody and should be ordered to remain in custody.

n The defendant must be ordered detained pursuant to 18 U.S.C. $ 31a3(aXl) unless the Court finds by clear and

convincing evidence that the defendant is not likely to flee or pose a danger to any other person or the community

if released.

tr The Government does not oppose release.

! The defendant has been compliant with the current conditions of release.

! I find by clear and convincing evidence that the defendant is not likely to flee or pose a danger to any

other person or the community if released and should therefore be released under $ 3142(b) or (c).

The Government opposes release.

The defendant has not been compliant with the conditions of release.

If the Court accepts this recommendation, this matter should be set for hearing upon motion of the

Government.

The defendant must be ordered detained pursuant to l8 U.S.C. $ 31a3(a)(2) unless (l)(a) the Court finds there is a

substantial likelihood that a motion for acquittal or new trial will be granted, or (b) the Government has

recommended that no sentence of imprisonment be imposed, or (c) exceptional circumstances are clearly shown

under $ 31a5(c) why the defendant should not be detained, and (2) the Court finds by clear and convincing

evidence that the defendant is not likely to flee or pose a danger to any other person or the community if released.

Date: August 16,2022

NOTICE

Failure to file written objections to this Report and Recommendation within fourteen (14) days from the date of

its service shall bar an aggrieved part5l from attacking such Report and Recommendation before the assigned United

States District Judge. 28 U.S.C. $636(bXlXB)'

n

tr

D

n

UNITED STATES

Case 3:22-cr-00084-N Document 29 Filed 08/16/22 Page 1 of 1 PageID 63
#### WOOTTON et al. v. DIXON.

Court of Appeals of Kentucky.

Nov. 13, 1952.

Leslie W. Morris, Frankfort, W. E. Faulkner, D. B. Wooton and Napier & Napier, Hazard, for appellants.

C. A. Noble, Flazard, for appellee.

WADDILL, Commissioner.

This is the third appeal of this case.

On the first appeal we held that the court erred in sustaining defendant’s motion for a peremptory instruction. The judgment was reversed and the case remanded to the circuit court for proceedings consistent with the opinion. Dixon v. Wootton, 307 Ky. 338, 210 S.W.2d 967.

On retrial of the case, plaintiff obtained judgment of $7,500. This judgment was reversed because of the court’s failure to give an instruction relative to the question of plaintiff’s intoxication. Wootton v. Dixon, 312 Ky. 521, 228 S.W.2d 428.

On the third trial a jury awarded plaintiff a verdict of $25,000. The injury suffered by plaintiff was a fracture of the cervical neck of the right femur which was received in a fall allegedly caused by a defect in some stair steps he was ascending in a building owned by the late Bailey P. Wootton. Reference is made to the former opinions of this Court (cited above) for a recitation of the facts.

The medical testimony disclosed that ap-pellee’s injury has resulted in a partial permanent disability of his right hip. He has a limited use of his hip but is unable to perform arduous tasks which require bending or lifting. His medical and hospital treatment were furnished by the U. S. Navy and no claim is made for special damages.

Under the evidence adduced, we think the jury’s verdict of $25,000 is excessive as it strikes our mind at first blush as having been superinduced by passion or prejudice.

For this reason the judgment is reversed.
Exhibit


EXHIBIT 10.2


SECOND AMENDMENT
TO
EXECUTIVE SEVERANCE AGREEMENT


THIS SECOND amendment to executive severance agreement (the “Second Amendment”) is made as of July 10, 2015 by and between David W. Trahan (“Executive”) and Conn’s, Inc. (the “Company”).


WHEREAS, the Company and Executive are parties to an Executive Severance Agreement, dated September 1, 2011, as amended by that Amendment to Severance Agreement, dated December 3, 2013 (collectively, the “Agreement”);


WHEREAS, the Company and Executive now desire to further amend the Agreement in the manner set forth herein and pursuant to the terms of this Second Amendment.


NOW, THEREFORE, IT IS HEREBY AGREED AS FOLLOWS: 
1.Section 1 of the Agreement is hereby amended and restated in its entirety to read as follows: 
“Term of Agreement.  This Agreement will commence on the Effective Date and will continue in effect for one (1) year from such date, and shall automatically renew for successive one (1) year periods unless terminated by mutual written agreement of Executive and Company prior to the end of the then-existing term.”
2.    Continuing Effect.  The parties hereby acknowledge and agree that, except as expressly amended hereby, the Agreement remains in full force and effect in accordance with its terms and that this Second Amendment, together with the Agreement, reflects the entire agreement of the parties hereto. Capitalized terms not otherwise defined in this Second Amendment shall have the meanings set forth in the Agreement.


 [Signature Page Follows]

    




IN WITNESS WHEREOF, the parties have executed this Second Amendment effective as of the date first written above.






	
				
	 
	 
	CONN'S, INC.

	 
	 
	By:
	/s/ Robert F. Bell

	 
	 
	Name:
	Robert F. Bell

	 
	 
	Title:
	Vice President and General Counsel




	
				
	 
	 
	EXECUTIVE

	 
	 
	By:
	/s/ David W. Trahan

	 
	 
	Name:
	David W. Trahan
This disposition is not appropriate for publication and is not precedent *

except as provided by 9th Cir. R. 36-3.

The panel unanimously concludes this case is suitable for decision **

without oral argument. See Fed. R. App. P. 34(a)(2).

NOT FOR PUBLICATION

UNITED STATES COURT OF APPEALS

 FOR THE NINTH CIRCUIT

ALFRED T. SAPSE,

 Plaintiff - Appellant,

 and

RENEE SAPSE, 

 Plaintiff,

 v.

JACK FERM,

 Defendant - Appellee.

No. 10-15850

D.C. No. 2:09-cv-00779-KJD-PAL

MEMORANDUM*

Appeal from the United States District Court

for the District of Nevada

Kent J. Dawson, District Judge, Presiding

Submitted October 25, 2011** 

Before: TROTT, GOULD, and RAWLINSON, Circuit Judges.

Alfred T. Sapse appeals pro se from the district court’s judgment dismissing

FILED

NOV 02 2011

MOLLY C. DWYER, CLERK

U.S. COURT OF APPEALS
2 10-15850

his action to set aside a prior judgment against him. We have jurisdiction under 28

U.S.C. § 1291. We review for an abuse of discretion the denial of leave to amend. 

Gardner v. Martino, 563 F.3d 981, 990 (9th Cir. 2009). We affirm.

The district court did not abuse its discretion by denying leave to amend the

complaint to plead fraud on the court because amendment would have been futile. 

See id. at 992 (district court did not abuse its discretion by denying leave to amend

where amendment would be futile); see also Appling v. State Farm Mut. Auto. Ins.

Co., 340 F.3d 769, 780 (9th Cir. 2003) (affirming dismissal of independent action

to set aside a judgment for fraud on the court because the alleged acts did not

constitute a “grave miscarriage of justice”).

Sapse’s remaining contentions are unpersuasive.

Appellee’s motion to strike the reply brief is denied.

AFFIRMED.
#### DAVIS v. STATE.

No. 25970.

Court of Criminal Appeals of Texas.

Oct 29, 1952.

No attorney on -appeal, for appellant.

George P. Blackburn, State’s Atty., Austin, for the State.

WOODLEY, Commissioner.

In this misdemeanor appeal the proceedings appear to be- regular, and no statement of facts or bills of exception are found in the record.

The judgment is affirmed.

Opinion approved by the court.
# QSBL 033114

# SBLF Summmary SB Lending 033114

# QSBL 123113

# QSBL 093013

# QSBL 063013

# QSBL 033113

# QSBL 123112

# QSBL 093012

# QSBL 063012

# QSBL 033112

# QSBL 123111

# QSBL 093011

# QSBL 063011

# QSBL 033111

# image1.png
Exhibit 32.1





CERTIFICATION PURSUANT TO


18 U.S.C. SECTION 1350,


AS ADOPTED PURSUANT TO


SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002


In connection with the Annual Report of Venture Lending & Leasing VIII, Inc. (the "Fund") on Form 10-K for the year ending December 31, 2015 as filed with the Securities and Exchange Commission on the date hereof (the "Report"), I, Maurice C. Werdegar, President and Chief Executive Officer of the Fund, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:


(1) The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and


(2) The information contained in the Report fairly presents, in all material respects, the financial condition and result of operations of the Fund.





/S/ Maurice C. Werdegar


Maurice C. Werdegar


President and Chief Executive Officer


March 15, 2016
1

IN THE UNITED STATES DISTRICT COURT

FOR THE NORTHERN DISTRICT OF TEXAS

FORT WORTH DIVISION

JENNIFER VANDERSTOK, et al.,

Plaintiffs,

v.

MERRICK GARLAND, in his official

capacity as Attorney General of the United States;

et al.,

Defendants.

Civil Action No. 4:22-cv-00691-O

[PROPOSED] ORDER GRANTING PLAINTIFFS’ REQUEST TO EXPAND

PRELIMINARY INJUNCTION

Before the Court is a Request to Expand Preliminary Injunction filed by Plaintiffs Jennifer

VanDerStok; Michael G. Andren; Tactical Machining, LLC; and Firearms Policy Coalition, Inc.

(“Plaintiffs”).

Upon consideration of Plaintiffs’ Request, it is hereby ORDERED that the Request is

GRANTED.

It is further ORDERED that Defendants and their officers, agents, and employees are

enjoined from implementing or enforcing the regulations established or amended by the

Department of Justice and Bureau of Alcohol, Tobacco, Firearms, and Explosives’ Final Rule

entitled Definition of “Frame or Receiver” and Identification of Firearms (“Final Rule”), 87 Fed.

Reg. 24,652 (Apr. 26, 2022), including the Corrections to the Final Rule entitled Definition of

“Frame or Receiver” and Identification of Firearms; Corrections, 78 Fed. Reg. 51,249 (Aug. 19,

2022).

//

Case 4:22-cv-00691-O Document 62-6 Filed 09/08/22 Page 1 of 2 PageID 891
2

Signed this _______________, 2022.

_____

UNITED STATES DISTRICT JUDGE REED O’CONNOR

Case 4:22-cv-00691-O Document 62-6 Filed 09/08/22 Page 2 of 2 PageID 892
H. J. Res. 111

One Hundred Third Congress

of the

United States of America

AT THE FIRST SESSION

Begun and held at the City of Washington on Tuesday,

the fifth day of January, one thousand nine hundred and ninety-three

Joint Resolution

Designating October 21, 1993, as ‘‘National Biomedical Research Day’’.

Whereas the biomedical research community in the United States

is recognized as the world leader in discovering knowledge that

promotes the health and well-being of people throughout the

world;

Whereas biomedical research offers the best hope for breakthroughs

in the detection and treatment of diseases in the future;

Whereas since 1900 biomedical research has helped increase the

lifespan of people in the United States by 25 years through

the development of vaccines, antibiotics, and anti-infective drugs;

Whereas biomedical research has contributed to the virtual elimination of epidemic diseases such as cholera, smallpox, yellow

fever, and bubonic plague, and in the United States biomedical

research has helped to prevent such childhood killers as polio,

diphtheria, tetanus, pertussis, and Sudden Infant Death Syndrome;

Whereas biomedical researchers are working diligently toward cures

for diseases such as Acquired Immune Deficiency Syndrome

(AIDS), Alzheimer’s disease, cancer, arthritis, diabetes, epilepsy,

multiple sclerosis, heart and lung diseases, mental illness, and

countless other diseases that afflict millions of people in the

United States;

Whereas the Congress has consistently demonstrated a financial

commitment to maintaining the preeminence of the United States

in biomedical research through support of such agencies as the

National Institutes of Health, the Alcohol, Drug Abuse and Mental Health Administration, the Centers for Disease Control, and

the Veterans Administration;

Whereas the products and byproducts of biomedical research

contribute to the health of the United States economy by reducing

medical costs through prevention of various diseases and by furthering the success of the United States in international commerce and trade;

Whereas biomedical research has led to drugs and vaccines that

safeguard the animals we raise and the food we consume, protecting the health of such animals as cattle, hogs, sheep, and chickens; and

Whereas biomedical research also has contributed to the health

and well-being of animals through vaccines for parvovirus, infectious canine hepatitis, rabies, distemper, anthrax, tetanus, and

feline leukemia, and has helped the prospects of endangered

species by reducing disease and promoting reproduction: Now,

therefore, be it
H. J. Res. 111—2

Resolved by the Senate and House of Representatives of the

United States of America in Congress assembled, That October

21, 1993, is designated as ‘‘National Biomedical Research Day’’,

and the President is authorized and requested to issue a proclamation calling upon the people of the United States to observe such

day with appropriate ceremonies and activities.

Speaker of the House of Representatives.

Vice President of the United States and

President of the Senate.
<TABLE> <S> <C>

<ARTICLE> 5
<LEGEND>
    THIS SCHEDULE CONTAINS SUMMARY FINANCIAL  INFORMATION EXTRACTED FROM PHOENIX
    GOLD INTERNATIONAL,  INC.'S FINANCIAL  STATEMENTS CONTAINED IN ITS QUARTERLY
    REPORT ON FORM 10-QSB FOR THE PERIOD  ENDING MARCH 31, 1997 AND IS QUALIFIED
    IN ITS ENTIRETY BY REFERENCE TO SUCH FINANCIAL STATEMENTS
</LEGEND>
<MULTIPLIER>                            1
       
<S>                                               <C>    
<PERIOD-TYPE>                                      6-MOS
<FISCAL-YEAR-END>                                  SEP-28-1997
<PERIOD-END>                                       MAR-31-1997
<CASH>                                                   2,602
<SECURITIES>                                                 0
<RECEIVABLES>                                        4,287,981
<ALLOWANCES>                                                 0
<INVENTORY>                                          8,241,415
<CURRENT-ASSETS>                                    13,621,157
<PP&E>                                               5,920,363
<DEPRECIATION>                                       2,266,055
<TOTAL-ASSETS>                                      18,297,182
<CURRENT-LIABILITIES>                                7,183,408
<BONDS>                                                662,333
<PREFERRED-MANDATORY>                                        0
<PREFERRED>                                                  0
<COMMON>                                             7,477,939
<OTHER-SE>                                           2,973,502
<TOTAL-LIABILITY-AND-EQUITY>                        18,297,182
<SALES>                                             11,835,706
<TOTAL-REVENUES>                                    11,835,706
<CGS>                                                9,360,529
<TOTAL-COSTS>                                       12,131,205
<OTHER-EXPENSES>                                             0
<LOSS-PROVISION>                                             0
<INTEREST-EXPENSE>                                     252,338
<INCOME-PRETAX>                                       (546,557)
<INCOME-TAX>                                          (209,000)
<INCOME-CONTINUING>                                   (337,557)
 <DISCONTINUED>                                              0
 <EXTRAORDINARY>                                             0
<CHANGES>                                                    0
<NET-INCOME>                                          (337,557)
<EPS-PRIMARY>                                             (.10)
<EPS-DILUTED>                                             (.10)

        

</TABLE>
Case 5:22-cr-00045-H-BV Document 46 Filed 07/08/22 Page 1 of 2 PageID 81
Case 5:22-cr-00045-H-BV Document 46 Filed 07/08/22 Page 2 of 2 PageID 82
April 19, 2017

VIA EDGAR

United States Securities and Exchange Commission

|Re: | First Mining Finance Corp. (the
      Company)
|--- | ------------------------------------------------
|    | Annual Report on Form 40-F                      
|    | Consent of Expert                               
|    |                                                 

This letter is provided in connection with the Companys Form
40-F annual report for the year ended December 31, 2016 (the Annual
Report) to be filed by the Company with the United States Securities and
Exchange Commission (the SEC). The Annual Report incorporates by
reference the Annual Information Form of the Company for the year ended December
31, 2016.

I, Michael Royle, M.App.Sci., P.Geo., of SRK Consulting
(Canada) Inc., hereby consent to the use of my name in connection with reference
to my involvement in the preparation of the following technical report:

Preliminary Economic Assessment for
the Springpole Gold Project, Ontario, Canada dated October 7, 2016 (the
Technical Report).

and to references to the Technical Report, or portions thereof,
in the Annual Report and to the inclusion and incorporation by reference of the
information derived from the Technical Report in the Annual Report.

Yours truly,

|/s/ Michael Royle, M.App.Sci., P.Geo.
|-------------------------------------
|Michael Royle, M.App.Sci., P.Geo.    
|Principal Hydrogeologist             
|SRK Consulting (Canada) Inc.
Case 3:22-cv-01807-D Document 152 Filed 11/20/24 Page 1 of 2 PageID 2214
Case 3:22-cv-01807-D Document 152 Filed 11/20/24 Page 2 of 2 PageID 2215